R&D Portfolio
Resources
Here you will find all our documents, brochures and posters of interest to you.
Posters
App. Notes
Gallery
Brochures
Blog
RESOURCES
Posters
Ensure the safety of your new molecule!
Our new application notes on CacoReady plates will show you how to accurately predict and stratify intestinal toxicity using cutting-edge methods like TEER and LY paracellular flux.
Get for free the latest protocol for acute toxicity assessment.
RESOURCES
Gallery
RESOURCES
Brochures
CacoFamily
FamilyPort
Our latest news
Honoring 20 years of dedication from our team
This year, we had the privilege of celebrating 20 years of dedication from four of our esteemed colleagues—Sheila Guisado, Lourdes Gombau, Alberto Corcho, and Marta Corvo.
Recommended reference compounds for permeability assays
Permeability assays are important for understanding how molecules cross biological barriers, assessing both their ability to cross and the mechanisms involved. While drugs are often absorbed by passive diffusion, some molecules can also be substrates for membrane proteins or transporters.
Caco-2 Permeability Assay Protocol
The permeability assay protocol for Caco-2 cells serves as a cornerstone in understanding and predicting the intestinal absorption of pharmaceutical agents.
MPS-LOC
The primary goal of this project is to develop liver-on-chip systems that integrate microfluidics, 3D printing, human-derived liver cells, and liver-derived bioinks.
3DLIVER
Readycell is leading the coordination of the 3DLIVER project, which is dedicated to creating innovative in vitro models from human liver tissue.
SEGURAM
Readycell’s expertise in in vitro permeability assays with Caco-2 cells has allowed the development of novel gut-on-a-chip model in Seguram.
BIOPRINTIA
ReadyCell collaborates in the BioPrintIA project as a specialized partner in the biotechnology sector.
STRETCHBIO
Readycell contributes to technical tasks by assessing the biocompatibility and adhesion properties of Caco-2 cells on nanodevices and optimizing the interface connecting nanodevices with biosamples. We also define and implement effective strategies for the exploitation and technology transfer of the StretchBio results based on our experience in the biomedical sector and our global network of distribution partners.
